Study Of Perennial Allergic Rhinitis

This study has been completed.

Sponsored by:	GlaxoSmithKline
Information provided by:	GlaxoSmithKline
ClinicalTrials.gov Identifier:	NCT00358475

Purpose

This study was designed to assess safety of an investigational nasal spray in the treatment of perennial allergic rhinitis. Perennial allergic rhinitis is triggered by house dust, mite and mold etc. Typical symptoms are sneezing, nasal congestion and pruritus and rhinorrhea.

Condition	Intervention	Phase
Perennial Allergic Rhinitis	Drug: GW685698	Phase III

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Single Group Assignment, Safety Study
Official Title:	Study of Perennial Allergic Rhinitis -Long Term Treatment Study-

Further study details as provided by GlaxoSmithKline:

Primary Outcome Measures:

Adverse events and laboratory blood test

Secondary Outcome Measures:

Change of nasal symptom score

Estimated Enrollment:	65
Study Start Date:	June 2005

Eligibility

Ages Eligible for Study:	16 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion criteria:

Informed consent.
Outpatient.
Diagnosis of perennial allergic rhinitis with symptoms.
Able to comply with study procedures.

Exclusion criteria:

Significant concomitant medical condition.
Use of corticosteroids/allergy medications.
Laboratory abnormality.
Positive pregnancy test.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00358475

Sponsors and Collaborators

GlaxoSmithKline

Investigators

Study Director:

GSK Clinical Trials, MD

GlaxoSmithKline

More Information

Responsible Party:	GSK ( Study Director )
Study ID Numbers:	FFR100688
Study First Received:	July 27, 2006
Last Updated:	October 13, 2008
ClinicalTrials.gov Identifier:	NCT00358475
Health Authority:	Japan: Ministry of Health, Labor and Welfare

Keywords provided by GlaxoSmithKline:

perennial allergic rhinitis

Study placed in the following topic categories:

Hypersensitivity
Otorhinolaryngologic Diseases
Respiratory Tract Infections
Respiratory Tract Diseases

Rhinitis, Allergic, Perennial
Hypersensitivity, Immediate
Rhinitis
Respiratory Hypersensitivity

Additional relevant MeSH terms:

Immune System Diseases
Nose Diseases

ClinicalTrials.gov processed this record on January 16, 2009